Related Experiment Video
Updated: Jun 23, 2026
09:03
Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
Published on: March 17, 2023
Current Status and Future Prospects for Cell Therapy Manufacturing at KNIH.
Hyunyoung Kim1,2, Jung-Hyun Kim3, Yong-Ou Kim4,5
1Division of Intractable Disease Research, Department of Chronic Convergence Research, Korea National Institute of Health, Cheongju, South Korea. inbiology@korea.kr.
Advances in Experimental Medicine and Biology
|October 24, 2025
Summary
The National Center for Stem Cell and Regenerative Medicine (NCSR) in Korea supports stem cell research and therapeutics development. It enhances Good Manufacturing Practice (GMP) infrastructure and international collaboration for regenerative medicine advancement.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Biopharmaceutical Development
Background:
- The National Center for Stem Cell and Regenerative Medicine (NCSR) in the Republic of Korea is pivotal for advancing stem cell research and clinical applications.
- Established to operate a stem cell bank and GMP-compliant facilities, it supports the development of stem cell-based therapeutics.
Purpose of the Study:
- To highlight the operational achievements of the NCSR.
- To detail its role in supporting clinical research and advancing stem cell therapeutics.
- To outline future strategies for enhancing regenerative medicine commercialization.
Main Methods:
- Standardization of high-quality human pluripotent stem cells for research distribution.
- Active engagement in international collaborations to improve research resource reliability.
- Implementation of laws supporting advanced regenerative medicine and biopharmaceuticals.
Main Results:
- The NCSR has established a robust stem cell bank and GMP-compliant manufacturing facilities.
- International collaborations have enhanced the reliability of research resources.
- The Republic of Korea has achieved a leading global position in regenerative medicine.
Conclusions:
- The NCSR's operational achievements and strategic initiatives are crucial for advancing stem cell therapeutics.
- Enhancing GMP infrastructure and international cooperation will promote commercialization of regenerative medicine.
- The center contributes to precision medicine and innovative healthcare solutions.
Keywords:
Clinical translationEmbryonic stem cells (ESCs)Genetic stability in stem cell therapiesGood Manufacturing Practice (GMP)Induced pluripotent stem cells (iPSCs)International collaborationNational Center for Stem Cell and Regenerative Medicine (NCSR)National Stem Cell Bank (NSCB)Organoid technologyQuality control in stem cell therapyRegulatory framework for advanced regenerative medicineMore Related Videos
Related Concept Videos
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...